P&TS celebrates the beginning of the New Year 2021 with the launch of its Biotech section. The creation of this new section enables P&TS to intensify its support for innovative projects in the biotech, medtech, pharmaceutical and agricultural sectors.
Residing on the solid scientific and industry experiences of Claudia Nash, molecular biologist, and Franck Amiot, organic chemist, the biotech team employs its in depth knowledge in these fields to develop efficient intellectual property strategies adapted to those fast-developing industries.
From IP strategy and protection, be it by patent, utility models or supplementary protection certificates, to licensing, P&TS is looking forward to accompanying its biotech clients in adding value to their products.
